114 related articles for article (PubMed ID: 23632916)
1. High p53 and MAP1 light chain 3A co-expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Wang ZB; Peng XZ; Chen SS; Ning FL; Du CJ; Wang K; Ma W; Cheng YF
Mol Med Rep; 2013 Jul; 8(1):41-6. PubMed ID: 23632916
[TBL] [Abstract][Full Text] [Related]
2. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
3. No prognostic significance of p53 expression in esophageal squamous cell carcinoma.
Kanamoto A; Kato H; Tachimori Y; Watanabe H; Nakanishi Y; Kondo H; Yamaguchi H; Gotoda T; Muro K; Matsumura Y
J Surg Oncol; 1999 Oct; 72(2):94-8. PubMed ID: 10518106
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Kurabayashi A; Sasaguri S; Araki K; Hayashi H; Ohtsuki Y
Oncology; 2004; 67(2):143-50. PubMed ID: 15539919
[TBL] [Abstract][Full Text] [Related]
6. Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival.
Sankalecha TH; Gupta SJ; Gaikwad NR; Shirole NU; Kothari HG
Saudi J Gastroenterol; 2017; 23(5):281-286. PubMed ID: 28937022
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
10. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Karashima R; Imamura Y; Ida S; Ishimoto T; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
Med Oncol; 2013 Dec; 30(4):728. PubMed ID: 24026664
[TBL] [Abstract][Full Text] [Related]
11. The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis.
Zhao Z; Wang P; Gao Y; He J
Cancer Med; 2017 Jan; 6(1):54-66. PubMed ID: 27882726
[TBL] [Abstract][Full Text] [Related]
12. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
15. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
[TBL] [Abstract][Full Text] [Related]
17. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
19. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb.
Nita ME; Nagawa H; Tominaga O; Tsuno N; Hatano K; Kitayama J; Tsuruo T; Domene CE; Muto T
Ann Surg Oncol; 1999; 6(5):481-8. PubMed ID: 10458687
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]